Updates

We have assisted a large company in setting up a patient support program.

We regularly assist clients with pricing and reimbursement procedures in the Netherlands.

We have negotiated clinical trial agreements on behalf of several sponsors.

We have advised pharmaceutical companies with legal advice across the full product lifecycle, from early-stage development through to market authorisation and post-marketing compliance.

Our team assisted a mid-sized cosmetics company with the negotiation of a distribution agreement.

We have assisted a diagnostics company with its companion diagnostics strategy, including the regulatory implications of combining diagnostic and therapeutic products.

We advised a mid-sized company on the qualification of a cosmetic product to facilitate its compliant and effective market launch.

Our team negotiated a cooperation agreement between a cosmetics brand owner and a manufacturer on behalf of a mid-sized company.

We have advised pharmacies on the regulatory aspects of pharmaceutical compounding.

Axon advised a stock-listed biopharmaceutical company on antibody licensing and technology transfer agreements with two major US-based pharmaceutical companies. The deals involved the grant of commercial rights to the licensor's proprietary antibody platform technology.